Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Switch from IV Epoprostenol to IV Remodulin in PAH
NCT00373360Phase 4Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Sep 2006
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Therapeutics Corporation. Started Sep 2006; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00373360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373360.